Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non–Small-Cell Lung Cancer: The Never-Ending Story
Cancer Research business.industry Wild type medicine.disease Oncology medicine Cancer research Growth factor receptor inhibitor In patient Non small cell Lung cancer business Tyrosine kinase Epidermal growth factor receptor tyrosine kinase